These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


583 related items for PubMed ID: 27899456

  • 1. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
    Newmeyer MN, Swortwood MJ, Barnes AJ, Abulseoud OA, Scheidweiler KB, Huestis MA.
    Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
    [Abstract] [Full Text] [Related]

  • 2. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
    Huestis MA, Sempio C, Newmeyer MN, Andersson M, Barnes AJ, Abulseoud OA, Blount BC, Schroeder J, Smith ML.
    J Anal Toxicol; 2020 Oct 12; 44(7):651-660. PubMed ID: 32369162
    [Abstract] [Full Text] [Related]

  • 3. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.
    Swortwood MJ, Newmeyer MN, Andersson M, Abulseoud OA, Scheidweiler KB, Huestis MA.
    Drug Test Anal; 2017 Jun 12; 9(6):905-915. PubMed ID: 27647820
    [Abstract] [Full Text] [Related]

  • 4. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
    Desrosiers NA, Lee D, Concheiro-Guisan M, Scheidweiler KB, Gorelick DA, Huestis MA.
    Clin Chem; 2014 Feb 12; 60(2):361-72. PubMed ID: 24185550
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers.
    Anizan S, Milman G, Desrosiers N, Barnes AJ, Gorelick DA, Huestis MA.
    Anal Bioanal Chem; 2013 Oct 12; 405(26):8451-61. PubMed ID: 23954944
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
    Spindle TR, Cone EJ, Schlienz NJ, Mitchell JM, Bigelow GE, Flegel R, Hayes E, Vandrey R.
    J Anal Toxicol; 2019 May 01; 43(4):233-258. PubMed ID: 30615181
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C, Scheidweiler KB, Barnes AJ, Huestis MA.
    Drug Test Anal; 2018 Mar 01; 10(3):518-529. PubMed ID: 28815938
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis.
    Scheidweiler KB, Schwope DM, Karschner EL, Desrosiers NA, Gorelick DA, Huestis MA.
    Clin Chem; 2013 Jul 01; 59(7):1108-17. PubMed ID: 23519966
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.